Intelerad CEO Jordan Bazinsky outlines how advanced technology and strategic partnerships can help medical imaging withstand financial, regulatory, and workforce pressures.
Key Details
- 1Medicare radiology reimbursement declined 3.4% in 2024 and 2.83% in 2025, part of a 25% decrease since 2005.
- 2FDA staff reductions may delay imaging device and AI tool approvals, affecting innovation availability.
- 3Radiologist workforce shortage persists; ARRT exam takers fell 18% between 2006 and 2022, with demand for CT and MRI rising 3-5% yearly.
- 4AI, integrated platforms, telehealth, and compliance tools are recommended to improve efficiency, care coordination, and regulatory adherence.
- 5Collaborations with vendors and academic institutions can mitigate outsourcing and strengthen the radiologist pipeline.
Why It Matters
Radiology leaders face mounting financial, regulatory, and workforce pressures. Embracing AI, integrated technology, and strategic partnerships is essential to sustaining operational excellence and ensuring continued patient care quality in the evolving medical imaging landscape.
Source
AuntMinnie
Related News
•Health Imaging
Most FDA-Cleared AI Devices Lack Pre-Approval Safety Data, Study Finds
A new study finds fewer than 30% of FDA-cleared AI medical devices reported key safety or adverse event data before approval.
•Health Imaging
BMI Significantly Impacts AI Accuracy in CT Lung Nodule Detection
New research demonstrates that high BMI negatively impacts both human and AI performance in chest low-dose CT interpretation, highlighting dataset diversity concerns.
•Radiology Business
Cigna Expands Nationwide Coverage for CT Imaging AI Tools
Cigna will reimburse for CT-based plaque analysis AI software for millions of members nationwide.